GLP1s reduce thirst and saliva production, and suppress appetite
The semaglutide program is ideal for individuals with a BMI of 30 or higher or a BMI of 27 coupled with a weight-associated condition such as hypertension, type 2 diabetes, or hypercholesterolemia
10.1016/j.cmet.2016.12.009 57 HuntingtonG
Hyperthyroidism Not treating overt hyperthyroidism increases the risk of extreme hyperthyroidism, also called a thyroid storm
One of the largest and most robust studies is the SURMOUNT-4 trial
"For consumers, the bottom line is simple: If a product claims to work 'just like a GLP-1 drug,' promises dramatic weight loss, or minimizes risk with slogans like 'all the benefits without the discomfort,' that should be a red flag," Ventura says